A “Bone” Fide Predictor of Metastasis? Predicting Breast Cancer Metastasis to Bone
- 20 May 2006
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (15), 2227-2229
- https://doi.org/10.1200/jco.2005.05.5319
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Genes Associated With Breast Cancer Metastatic to BoneJournal of Clinical Oncology, 2006
- Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk FactorsJournal of Clinical Oncology, 2005
- Genes that mediate breast cancer metastasis to lungNature, 2005
- Expression Profiling of Primary Tumors and Matched Lymphatic and Lung Metastases in a Xenogeneic Breast Cancer ModelThe American Journal of Pathology, 2005
- Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerThe Lancet, 2005
- Toxic acute tubular necrosis following treatment with zoledronate (Zometa)Kidney International, 2003
- Safety in iron managementAmerican Journal of Kidney Diseases, 2003
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Bone Marrow Suppression After Strontium-89 Therapy and Local Radiation Therapy in Patients With Diffuse Marrow InvolvementClinical Nuclear Medicine, 1997
- Strontium-89 Chloride (Metastron) for Palliative Treatment of Bony Metastases: The University of Minnesota ExperienceAmerican Journal of Clinical Oncology, 1996